Stock CARM CARISMA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Carisma Therapeutics, Inc.

Equities

CARM

US14216R1014

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
1.55 USD -2.82% Intraday chart for Carisma Therapeutics, Inc. -4.91% -47.10%
May. 02 Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer CI
Apr. 11 BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference
PR
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics : Corporate Presentation May 2024
PU
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
PR
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
CI
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy Annual Meeting
AQ
BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target
MT
Carisma Therapeutics to Present at Upcoming Conferences
PR
HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating
MT
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Carisma Therapeutics Q4 Net Loss Narrows, Revenue Rises; Plans Job Cuts in Q2 -- Shares Decline
MT
Carisma Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Carisma Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Carisma Therapeutics Announces Changes to its Board of Directors
PR
Carisma Therapeutics, Inc. Announces Changes to Its Board of Directors
CI
North American Morning Briefing : Stock Futures -2-
DJ
North American Morning Briefing : Inflation Data -2-
DJ
Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
PR
Carisma Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR
Carisma Therapeutics' First Lead Candidate Under Moderna Deal to Target Cancer Treatment
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CARM Stock
  4. News Carisma Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW